| Primary |
| Product Used For Unknown Indication |
38.1% |
| Drug Use For Unknown Indication |
17.0% |
| Prostate Cancer |
14.9% |
| Endometriosis |
13.6% |
| Uterine Leiomyoma |
4.5% |
| Hypertension |
2.3% |
| Pain |
1.4% |
| Vitamin Supplementation |
0.9% |
| Depression |
0.9% |
| Asthma |
0.8% |
| Blood Cholesterol Increased |
0.7% |
| Anxiety |
0.7% |
| Prophylaxis |
0.7% |
| Migraine |
0.6% |
| Menorrhagia |
0.6% |
| Pelvic Pain |
0.6% |
| Diabetes Mellitus |
0.5% |
| Insomnia |
0.5% |
| Mineral Supplementation |
0.5% |
| Hypothyroidism |
0.5% |
|
| Hot Flush |
13.8% |
| Death |
8.8% |
| Vaginal Haemorrhage |
8.5% |
| Weight Increased |
8.4% |
| Headache |
7.4% |
| Pain |
6.3% |
| Nausea |
4.6% |
| Prostatic Specific Antigen Increased |
4.1% |
| Pain In Extremity |
3.9% |
| Vomiting |
3.7% |
| Weight Decreased |
3.7% |
| Drug Ineffective |
3.4% |
| Prostate Cancer Metastatic |
3.4% |
| Menorrhagia |
3.2% |
| Prostate Cancer |
3.0% |
| Pelvic Pain |
2.9% |
| Metrorrhagia |
2.8% |
| Rash |
2.8% |
| Hospitalisation |
2.7% |
| Insomnia |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
28.8% |
| Endometriosis |
15.1% |
| Drug Use For Unknown Indication |
11.2% |
| Prostate Cancer |
9.6% |
| Uterine Leiomyoma |
7.4% |
| Asthma |
3.7% |
| Menorrhagia |
3.0% |
| Hypertension |
2.7% |
| Pain |
2.5% |
| Hypersensitivity |
2.2% |
| Vitamin Supplementation |
1.8% |
| Mineral Supplementation |
1.8% |
| Pelvic Pain |
1.7% |
| Vaginal Haemorrhage |
1.7% |
| Anaemia |
1.5% |
| Dysmenorrhoea |
1.4% |
| Prophylaxis |
1.3% |
| Cyst Removal |
0.9% |
| Migraine |
0.8% |
| Depression |
0.8% |
|
| Vaginal Haemorrhage |
15.3% |
| Weight Increased |
14.1% |
| Hot Flush |
8.2% |
| Prostatic Specific Antigen Increased |
6.5% |
| Pain |
6.3% |
| Menorrhagia |
5.9% |
| Drug Ineffective |
4.8% |
| Paraesthesia |
3.6% |
| Uterine Leiomyoma |
3.6% |
| Off Label Use |
3.4% |
| Urticaria |
3.4% |
| Headache |
2.9% |
| Nausea |
2.9% |
| Vomiting |
2.9% |
| Death |
2.7% |
| Incorrect Dose Administered |
2.7% |
| Pain In Extremity |
2.7% |
| Pelvic Pain |
2.7% |
| Weight Decreased |
2.7% |
| Insomnia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
50.3% |
| Prostate Cancer |
8.2% |
| Drug Use For Unknown Indication |
5.4% |
| Prostate Cancer Metastatic |
4.4% |
| Crohn's Disease |
3.5% |
| Diabetes Mellitus |
3.0% |
| Hypertension |
3.0% |
| Back Pain |
2.6% |
| Pain |
2.3% |
| Breast Cancer |
2.1% |
| Migraine |
1.9% |
| Osteoporosis |
1.9% |
| Prophylaxis |
1.9% |
| Hypothyroidism |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Fibromyalgia |
1.4% |
| Menorrhagia |
1.4% |
| Blood Pressure |
1.2% |
| Insomnia |
1.2% |
| Neuropathy Peripheral |
1.2% |
|
| Weight Decreased |
12.5% |
| Intervertebral Disc Protrusion |
8.3% |
| Pancreatitis Acute |
6.3% |
| Pyrexia |
6.3% |
| Rash |
6.3% |
| Renal Failure |
6.3% |
| Urticaria |
6.3% |
| Conduction Disorder |
4.2% |
| Goitre |
4.2% |
| Haematuria |
4.2% |
| Heparin-induced Thrombocytopenia |
4.2% |
| Malignant Neoplasm Progression |
4.2% |
| Pain |
4.2% |
| Palpitations |
4.2% |
| Tinnitus |
4.2% |
| Vomiting |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Anger |
2.1% |
| Appendicitis |
2.1% |
| Atrial Tachycardia |
2.1% |
|
